LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma
Top Cited Papers
Open Access
- 5 June 2024
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 595, 217025
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinomaCancer Cell, 2023
- Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycleMedical Oncology, 2023
- Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS/AMPK/mTOR pathwayPhytotherapy Research, 2023
- Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cellsMolecular Cell, 2022
- LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseasesMolecular Metabolism, 2021
- Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancerLife Sciences, 2020
- Cellular Senescence: Defining a Path ForwardCell, 2019
- Cellular Senescence: A Translational PerspectiveEBioMedicine, 2017
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001